These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 29948596

  • 1. Effect of Essential Oil on Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Pilot Randomized Controlled Trial.
    Ying J, Zhou MJ, Chen HY, Chen L, Zhang W, Ji J, Yu C, Zhang ZJ.
    Chin J Integr Med; 2019 Feb; 25(2):91-95. PubMed ID: 29948596
    [Abstract] [Full Text] [Related]

  • 2. Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
    Mehik A, Alas P, Nickel JC, Sarpola A, Helström PJ.
    Urology; 2003 Sep; 62(3):425-9. PubMed ID: 12946740
    [Abstract] [Full Text] [Related]

  • 3. Treatment of refractory category III nonbacterial chronic prostatitis/chronic pelvic pain syndrome with intraprostatic injection of onabotulinumtoxinA: a prospective controlled study.
    Abdel-Meguid TA, Mosli HA, Farsi H, Alsayyad A, Tayib A, Sait M, Abdelsalam A.
    Can J Urol; 2018 Apr; 25(2):9273-9280. PubMed ID: 29680006
    [Abstract] [Full Text] [Related]

  • 4. Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
    Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C.
    BMC Urol; 2015 Dec 07; 15():120. PubMed ID: 26643109
    [Abstract] [Full Text] [Related]

  • 5. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr 07; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.
    Zhang K, Liu Y, Yang W, Wang J, Yang J, Zhang G, Bai W, Chen S.
    Urology; 2021 Jul 07; 153():264-269. PubMed ID: 33482135
    [Abstract] [Full Text] [Related]

  • 7. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y, Naito Y, Funahashi Y, Ishida S, Fujita T, Tochigi K, Kato M, Gotoh M.
    Neurourol Urodyn; 2020 Sep 07; 39(7):1994-2002. PubMed ID: 32648985
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
    Wang J, Yan D, Liang K, Xu Z.
    Int Urol Nephrol; 2016 Jan 07; 48(1):13-8. PubMed ID: 26577998
    [Abstract] [Full Text] [Related]

  • 9. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D, Wang P, Chen J, Wang S, Jiang H.
    Chin Med J (Engl); 2011 Jul 07; 124(14):2158-61. PubMed ID: 21933619
    [Abstract] [Full Text] [Related]

  • 10. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC.
    BJU Int; 2012 Oct 07; 110(7):1014-22. PubMed ID: 22471591
    [Abstract] [Full Text] [Related]

  • 11. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
    Falahatkar S, Shahab E, Gholamjani Moghaddam K, Kazemnezhad E.
    BJU Int; 2015 Oct 07; 116(4):641-9. PubMed ID: 25307409
    [Abstract] [Full Text] [Related]

  • 12. Comparison of transcutaneous tibial nerve stimulation versus percutaneous tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain syndrome: A randomized prospective trial.
    Sevim M, Alkiş O, Kartal İG, Kazan HO, İvelik Hİ, Aras B, Kabay Ş.
    Prostate; 2023 Jun 07; 83(8):751-758. PubMed ID: 36871235
    [Abstract] [Full Text] [Related]

  • 13. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E, Salemi M, Sidoti G, Malaguarnera M, Castiglione R.
    Nutrients; 2017 Nov 03; 9(11):. PubMed ID: 29099760
    [Abstract] [Full Text] [Related]

  • 14. Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.
    Wagenlehner FM, Ballarini S, Naber KG.
    World J Urol; 2014 Dec 03; 32(6):1595-603. PubMed ID: 24482313
    [Abstract] [Full Text] [Related]

  • 15. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
    Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J.
    Urology; 2003 Oct 03; 62(4):614-7. PubMed ID: 14550427
    [Abstract] [Full Text] [Related]

  • 16. Clinical study of duloxetine hydrochloride combined with doxazosin for the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome: An observational study.
    Zhang M, Li H, Ji Z, Dong D, Yan S.
    Medicine (Baltimore); 2017 Mar 03; 96(10):e6243. PubMed ID: 28272220
    [Abstract] [Full Text] [Related]

  • 17. Effects of Electroacupuncture with Different Waveforms on Chronic Prostatitis/Chronic Pelvic Pain Syndromes: A Randomized Controlled Trial.
    Li Z, Liu J, Liu P, Zhang Y, Han W.
    Contrast Media Mol Imaging; 2022 Mar 03; 2022():6866000. PubMed ID: 35935300
    [Abstract] [Full Text] [Related]

  • 18. Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
    Choe HS, Lee SJ, Han CH, Shim BS, Cho YH.
    J Infect Chemother; 2014 Jan 03; 20(1):20-5. PubMed ID: 24462419
    [Abstract] [Full Text] [Related]

  • 19. [Effects of Huafenqinutang and vardenafil for treatment of chronic prostatitis/chronic pelvic pain syndrome with concomitant erectile dysfunction].
    Lin ZF, Chen BT, Zeng K, Lan HM, Wun J.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr 03; 27(4):532-4. PubMed ID: 17545052
    [Abstract] [Full Text] [Related]

  • 20. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review.
    Franco JVA, Turk T, Jung JH, Xiao YT, Iakhno S, Garrote V, Vietto V.
    BJU Int; 2019 Aug 03; 124(2):197-208. PubMed ID: 30019814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.